Treatment of multidrug resistant advanced alveolar soft part sarcoma with sunitinib

American Journal of Therapeutics
Abhimanyu GhoseSalvatore Veltri

Abstract

Sunitinib is a tyrosine kinase/angiogenesis inhibitor with proven efficacy in gastrointestinal stromal tumor and advanced renal cell carcinoma. We are presenting the case report of a patient with aggressive alveolar soft part sarcoma with lung and bone metastases, who had failed multiple chemotherapy regimens showing significant response to sunitinib. There was not only complete regression of the primary tumor, stabilization of his bone metastases and significant improvement in the quality of life. Our report shows that sunitinib has the capability of playing a pivotal role in the management of non-gastrointestinal stromal tumors like alveolar soft part sarcoma. Further research and trials must be encouraged over the use of this drug as it is most definitely promising.

References

Jan 12, 2007·The New England Journal of Medicine·Robert J MotzerRobert A Figlin
Mar 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laura Q M Chow, S Gail Eckhardt
Mar 21, 2007·Biochemical and Biophysical Research Communications·Robert Roskoski
Feb 4, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Silvia StacchiottiSilvana Pilotti
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne GeorgeMary L Keohan

❮ Previous
Next ❯

Citations

May 23, 2012·Current Treatment Options in Oncology·Ann W Silk, Scott M Schuetze
Jan 21, 2017·Expert Review of Anticancer Therapy·Akash TiwariSameer Bakhshi
Jan 20, 2018·Pediatric Blood & Cancer·Ricardo J FloresRajkumar Venkatramani
Jul 6, 2017·Oncotarget·Yong ZhouChongqi Tu
Oct 28, 2019·Annual Review of Cancer Biology·Rushika M PereraAndrea Ballabio
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Mohammad Hasan SoheilifarMohammad Reza Motie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
S StacchiottiS Pilotti
Journal of Gastrointestinal Cancer
Odile Jeanniard-MaletMarc Giovannini
Annals of Oncology : Official Journal of the European Society for Medical Oncology
S StacchiottiP G Casali
© 2021 Meta ULC. All rights reserved